Biologicals · 2024 · 12 citations · 9 references
Life SciencesImmunologyMicrobiologyClinical ImmunologyGood Laboratory PracticeGood Manufacturing PracticeBiological Hazard ControlDisease ControlImmune RegulationMicrobial ControlCapacity Building FrameworksEnvironmental Safety AssessmentGood Manufacturing Practice ComplianceInfection Control RegulationsInfectious Disease ManagementMicrobial Hazard ControlPathogen Load ManagementPre-existing Immunity
Many aspects of Controlled Human Infection Models (CHIMs, also known as human challenge studies and human infection studies) have been discussed extensively, including Good Manufacturing Practice (GMP) production of the challenge agent, CHIM ethics, environmental safety in CHIM, recruitment, community engagement, advertising and incentives, pre-existing immunity, and clinical, immunological, and microbiological endpoints. The fourth CHIM meeting focused on regulation of CHIM studies, bringing together scientists and regulators from high-, middle-, and low-income countries, to discuss barriers and hurdles in CHIM regulation. Valuable initiatives for regulation of CHIMs have already been undertaken but further capacity building remains essential. The Wellcome Considerations document is a good starting point for further discussions.
9
Wilbur H. Chen, Mitchell B. Cohen, Beth D. Kirkpatrick et al. · Clinical Infectious Diseases · 2016 · 198 citations · Full text
Carol O. Tacket, Mitchell B. Cohen, Steven S. Wasserman et al. · Infection and Immunity · 1999 · 173 citations · Full text
In-Kyu Yoon, Anon Srikiatkhachorn, Maria Theresa Alera et al. · International Journal of Infectious Diseases · 2020 · 45 citations · Full text